CHROMOPHOBE RENAL CELL CARCINOMA

CHROMOPHOBE RENAL CELL CARCINOMA was reported 45 times

CHROMOPHOBE RENAL CELL CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antihypoglycemic Agent [EPC] 1 0.0002
1 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
2 Glinide [EPC] 1 0.0001
3 Purine Antimetabolite [EPC] 11 0.0001
4 Antimetabolite Immunosuppressant [EPC] 2 0.0001
5 Calcineurin Inhibitor Immunosuppressant [EPC] 11 0.0001
6 GLP-2 Analog [EPC] 1 0.0001
7 Rifamycin Antibacterial [EPC] 2 0.0001
8 Interleukin-17A Antagonist [EPC] 2 0.0001
9 Bile Acid [EPC] 1 0.0000
10 Alkaloid [EPC] 1 0.0000
11 Provitamin D2 Compound [EPC] 1 0.0000
12 Nitrate Vasodilator [EPC] 2 0.0000
13 Tetracycline-class Drug [EPC] 1 0.0000
14 Androgen Receptor Inhibitor [EPC] 1 0.0000
15 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
16 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
17 Integrin Receptor Antagonist [EPC] 1 0.0000
18 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
19 Interferon beta [EPC] 2 0.0000
20 Corticosteroid [EPC] 13 0.0000
21 Interleukin-23 Antagonist [EPC] 1 0.0000
22 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
23 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
24 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
25 Kinase Inhibitor [EPC] 4 0.0000
26 Aldosterone Antagonist [EPC] 1 0.0000
27 Alkylating Drug [EPC] 1 0.0000
28 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
29 Factor Xa Inhibitor [EPC] 1 0.0000
30 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
33 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
35 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
36 Platelet Aggregation Inhibitor [EPC] 1 0.0000
37 Proton Pump Inhibitor [EPC] 1 0.0000